The Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support Strategies to Increase Participant Diversity, Inclusion and Engagement in Clinical Studies (NOT-NS-21-025) provides an opportunity for clinical trials and studies funded by the NIH Helping to End Addiction Long-termSM (HEAL) Initiative to address challenges of recruitment, retention, and engagement of populations suffering from pain and opioid use disorder.
NIH will support supplements to current HEAL awards that would enhance their patient, community, and other stakeholder engagement efforts and/or improve recruitment, retention, and inclusion of participants from underrepresented racial and ethnic groups in the United States. This supplement program will not support research on basic processes but will support implementation strategies to enhance stakeholder engagement, diversity, and inclusion in HEAL clinical studies. Activities proposed must be within the scope of the approved aims of the parent HEAL award.
The HEAL InitiativeSM is an aggressive NIH-wide effort to speed scientific solutions to stem the national opioid crisis. Almost every NIH Institute and Center is accelerating research to address this public health emergency from all angles.
Applications for these administrative supplements are due April 30, 2021. More information is available here.